RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway
RGS20通过内在抑制WNT/β-catenin信号通路来降低胶质瘤干细胞特性和替莫唑胺耐药性。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-30291-z
Xie, Yang; Li, Qi; Ma, Yecheng; Yang, Yongchang; Jin, Xingyu; Yi, Tailong; Ge, Xianglian; Xu, Xing; Yang, Xuejun; Huang, Qiang; Lu, Yalin; Li, Peng; Li, Wenliang; Wang, Xiaoguang; Piao, Yingzhe; Jin, Xun
发育与干细胞
细胞生物学
信号转导
RGS2
干细胞
胶质瘤